A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses

Archives of Dermatology

Volumn 139, Issue 4, 2003, Pages 451-455

  Darlington, Steven ^a   Williams, Gail ^b   Neale, Rachel ^a,c   Frost, Christine ^a   Green, Adèle ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; PLACEBO; SUNSCREEN;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; OUTCOMES RESEARCH; PHOTOMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SKIN CANCER;

ADULT; AGED; BETA CAROTENE; HUMANS; KERATOSIS; MIDDLE AGED; SUNLIGHT; SUNSCREENING AGENTS;

EID: 0344522708     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.4.451     Document Type: Article

References (15)

1. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer. 1998;78:144-148.
2. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30:774-778.
3. Levi F, Erler G, Te VC, Randimbison L, La Vecchia C. Trends in skin cancer incidence in Neuchatel, 1976-98. Tumori. 2001;87:288-289.
4. Green A, Battistutta D, Hart V, Leslie D, Weedon D, for the Nambour Study Group. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. Am J Epidemiol. 1996;144:1034-1040.
5. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-797.
6. Frost C, Williams G, Green A. High incidence and regression rates of solar keratoses in a Queensland community. J Invest Dermatol. 2000;115:273-277.
7. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147-1151.
8. Naylor MF, Boyd FA, Smith DW, Cameron GS, Hubbard D, Neldner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131:170-175.
9. Black HS, Herd JA, Goldberg LH, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med. 1994;330:1272-1275.
10. Mathews-Roth MM, Krinsky NI. Carotenoids affect development of UV-B induced skin cancer. Photochem Photobiol. 1987;46:507-509.
11. Lambert LA, Wamer WG, Wei RR, Lavu S, Chirtel SJ, Kornhauser A. The protective but nonsynergistic effect of dietary beta-carotene and vitamin E on skin tumorigenesis in Skh mice. Nutr Cancer. 1994;21:1-12.
12. Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of BCC and SCC of the skin: a randomised controlled trial. Lancet. 1999;354:723-729.
13. Green A, Battistutta D, Hart V, et al. The Nambour skin cancer and actinic eye disease prevention trial: design and baseline characteristics of participants. Control Clin Trials. 1994;15:512-522.
14. Mathews-Roth M, Pathak U, Fitzpatrick T, Harber L, Kass E. Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA. 1974;228: 1004-1008.
15. Leventhal H, Nerenz DR, Leventhal EA, Love RR, Bendena LM. The behavioral dynamics of clinical trials. Prev Med. 1991;20:132-146.